HAPLN1 and neoplasm: GSEA analysis of RNA-Seq data also showed that HAPLN1 is not only linked to pathways related to drug resistance but it may have a wider role in orchestrating the intra-tumoral inflammatory milieu and balancing anti-tumor immunity.